Table 2.

Characteristics of the sRNA sequences obtained in the present study.

Mouse groups	Sample code	Raw reads	Clean reads	Bases	Error rate (%)	Q20 (%)a	Q30 (%)b	GC content (%)
11 days post infection
Infected	I	13,723,453	13,562,928	0.686G	0.01	0.9686	0.9291	48.84
Infected	II	18,544,336	18,245,384	0.927G	0.01	0.977	0.9508	48.68
Infected	III	14,433,684	14,190,848	0.722G	0.01	0.9689	0.9288	48.44
Control	IV	10,419,259	10,237,888	0.521G	0.01	0.9729	0.942	48.61
Control	V	16,971,162	16,541,211	0.849G	0.01	0.9575	0.921	48.62
Control	VI	12,876,002	12,595,020	0.644G	0.01	0.9657	0.9323	49.96
33 days post infection
Infected	VII	10,271,598	10,143,170	0.541G	0.01	0.9648	0.9193	48.7
Infected	VIII	13,822,880	13,609,247	0.691G	0.01	0.969	0.9304	48.44
Infected	IX	13,012,055	12,786,416	0.651G	0.01	0.9631	0.9199	48.48
Control	X	17,410,567	16,970,788	0.871G	0.01	0.9553	0.9169	48.68
Control	XI	13,847,968	13,569,857	0.692G	0.01	0.9728	0.9432	48.89
Control	XII	12,009,258	11,825,447	0.600G	0.01	0.9695	0.9309	49.19

^aThe percentage of bases with a Phred value > 20.

^bThe percentage of bases with a Phred value > 30.